SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-18-001959
Filing Date
2018-01-04
Accepted
2018-01-04 16:31:30
Documents
1
Period of Report
2018-01-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3872
  Complete submission text file 0001209191-18-001959.txt   5303
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Issuer) CIK: 0001442836 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5425 WISCONSIN AVENUE SUITE 800 CHEVY CHASE MD 20815
Business Address
Nayeem Sara M. (Reporting) CIK: 0001709110 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38129 | Film No.: 18510523